Compile Data Set for Download or QSAR
Report error Found 59 Enz. Inhib. hit(s) with all data for entry = 50010299
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093042(N-[3'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  600nMAssay Description:Inhibitory activity against human beta-3 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093036(N-[6-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataEC50:  37nMAssay Description:Percent adenylyl cyclase activation at 10000 nM of compound concentrationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093033(N-[3'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  1.00E+4nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093035(N-[4-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataEC50:  4nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-3 adrenergic receptor (AR) at a concentration of 100 nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093033(N-[3'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  360nMAssay Description:Inhibitory activity against human beta-3 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093039(4-(3,5-Diiodo-4-methoxy-benzyl)-4,5,6,7-tetrahydro...)
Affinity DataEC50:  800nMAssay Description:Inhibitory activity against human beta-3 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093034(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  970nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50019355(1-(3,4,5-Trimethoxy-benzyl)-1,2,3,4-tetrahydro-iso...)
Affinity DataEC50:  14nMAssay Description:Compound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093038(1-(3',4',5'-Trimethoxy-biphenyl-4-ylmethyl)-1,2,3,...)
Affinity DataEC50:  27nMAssay Description:Inhibitory activity against human beta-3 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093041(N-[6-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataEC50:  7nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-3 adrenergic receptor (AR) at a concentration of 100 nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093040(N-[4-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataEC50:  36nMAssay Description:Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindololMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093036(N-[6-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataEC50:  78nMAssay Description:Inhibitory activity against human beta-3 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093042(N-[3'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093034(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  140nMAssay Description:Inhibitory activity against human beta-3 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50019355(1-(3,4,5-Trimethoxy-benzyl)-1,2,3,4-tetrahydro-iso...)
Affinity DataEC50:  1.70nMAssay Description:Inhibitory activity against human beta-3 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093037(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  16nMAssay Description:Inhibitory activity against human beta-3 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093040(N-[4-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataEC50:  66nMAssay Description:Inhibitory activity against human beta-3 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093044(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  1.80E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093044(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  6nMAssay Description:Inhibitory activity against human beta-3 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093043(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  10nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-3 adrenergic receptor (AR) at a concentration of 100 nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093038(1-(3',4',5'-Trimethoxy-biphenyl-4-ylmethyl)-1,2,3,...)
Affinity DataEC50:  6.10E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093039(4-(3,5-Diiodo-4-methoxy-benzyl)-4,5,6,7-tetrahydro...)
Affinity DataEC50:  1nMAssay Description:Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindololMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50019355(1-(3,4,5-Trimethoxy-benzyl)-1,2,3,4-tetrahydro-iso...)
Affinity DataEC50:  3.5nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-2 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093037(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  2.40E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093037(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  580nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-2 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093038(1-(3',4',5'-Trimethoxy-biphenyl-4-ylmethyl)-1,2,3,...)
Affinity DataEC50:  1.50E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-2 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093040(N-[4-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataEC50:  19nMAssay Description:Percent adenylyl cyclase activation at 10000 nM of compound concentrationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093039(4-(3,5-Diiodo-4-methoxy-benzyl)-4,5,6,7-tetrahydro...)
Affinity DataEC50:  2nMAssay Description:Percent adenylyl cyclase activation at 10000 nM of compound concentrationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093033(N-[3'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  2.70E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-2 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093034(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  1.30E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-2 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093042(N-[3'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-2 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093036(N-[6-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataEC50:  3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nmMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093044(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataEC50:  340nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-2 adrenergic receptor (AR)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50019355(1-(3,4,5-Trimethoxy-benzyl)-1,2,3,4-tetrahydro-iso...)
Affinity DataIC50: 6.10nMAssay Description:Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-2 adrenergic receptor (AR) in the presence of [...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50019355(1-(3,4,5-Trimethoxy-benzyl)-1,2,3,4-tetrahydro-iso...)
Affinity DataIC50: 6.10nMAssay Description:Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093039(4-(3,5-Diiodo-4-methoxy-benzyl)-4,5,6,7-tetrahydro...)
Affinity DataIC50: 56nMAssay Description:Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindololMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093037(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataIC50: 160nMAssay Description:Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-2 adrenergic receptor (AR) in the presence of [...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093040(N-[4-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataIC50: 200nMAssay Description:Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindololMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093035(N-[4-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataIC50: 300nMAssay Description:Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindololMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093041(N-[6-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataIC50: 300nMAssay Description:Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindololMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093033(N-[3'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataIC50: 530nMAssay Description:Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093033(N-[3'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataIC50: 710nMAssay Description:Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindololMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093038(1-(3',4',5'-Trimethoxy-biphenyl-4-ylmethyl)-1,2,3,...)
Affinity DataIC50: 760nMAssay Description:Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindololMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093039(4-(3,5-Diiodo-4-methoxy-benzyl)-4,5,6,7-tetrahydro...)
Affinity DataIC50: 780nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nmMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093043(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataIC50: 990nMAssay Description:Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindololMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093041(N-[6-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nmMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093035(N-[4-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nmMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093040(N-[4-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin...)
Affinity DataIC50: 1.20E+3nMAssay Description:Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nmMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093038(1-(3',4',5'-Trimethoxy-biphenyl-4-ylmethyl)-1,2,3,...)
Affinity DataIC50: 1.80E+3nMAssay Description:Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50093037(N-[4'-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinoli...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 59 total ) | Next | Last >>
Jump to: